We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$9.86M
1-Year Est. Return
9.93%
This Fund
S&P 500
This Quarter
Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
(+11%)
Cap. Flow
+$23.3M
Cap. Flow
% of AUM
11.78%
Top 10 Holdings %
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Delek US
DK
|
+$871K |
| 2 |
Broadcom
AVGO
|
+$691K |
| 3 |
Agilent Technologies
A
|
+$650K |
| 4 |
Telos
TLS
|
+$640K |
| 5 |
Pagaya Technologies
PGY
|
+$627K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Array Technologies
ARRY
|
+$730K |
| 2 |
Vertiv
VRT
|
+$639K |
| 3 |
Zevra Therapeutics
ZVRA
|
+$635K |
| 4 |
BOW
Bowhead Specialty Holdings
BOW
|
+$608K |
| 5 |
Rigel Pharmaceuticals
RIGL
|
+$581K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Industrials | 15.13% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 11.79% |
| 5 | Healthcare | 11.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Madison Square Garden
MSGE
$3.65B
| $298K | 0.15% |
+5,536
| New | +$266K |
|
277
Polaris
PII
$4.07B
| $298K | 0.15% |
4,711
+190
| +4% | +$12.5K |
|
278
Sibanye-Stillwater
SBSW
$5.93B
| $298K | 0.15% |
20,895
+435
| +2% | +$5.26K |
|
279
Microsoft
MSFT
$2.92T
| $296K | 0.15% |
613
-110
| -15% | -$55.1K |
|
280
Business First Bancshares
BFST
$1.05B
| $296K | 0.15% |
+11,334
| New | +$287K |
|
281
United Natural Foods
UNFI
$3.07B
| $295K | 0.15% |
+8,756
| New | +$326K |
|
282
IBEX
IBEX
$480M
| $295K | 0.15% |
+7,716
| New | +$285K |
|
283
Phibro Animal Health
PAHC
$1.48B
| $294K | 0.15% |
+7,881
| New | +$320K |
|
284
Stepan Co
SCL
$1.32B
| $294K | 0.15% |
6,203
+1,357
| +28% | +$62.1K |
|
285
Comcast
CMCSA
$85.8B
| $293K | 0.15% |
9,809
+629
| +7% | +$17.9K |
|
286
California Water Service
CWT
$3.14B
| $293K | 0.15% |
+6,756
| New | +$308K |
|
287
Flexsteel Industries
FLXS
$317M
| $292K | 0.15% |
+7,404
| New | +$289K |
|
288
Hanmi Financial
HAFC
$947M
| $291K | 0.15% |
+10,764
| New | +$288K |
|
289
Under Armour
UAA
$3.04B
| $290K | 0.15% |
58,270
+38,750
| +199% | +$179K |
|
290
Green Plains
GPRE
$1.15B
| $289K | 0.15% |
29,530
-16,869
| -36% | -$170K |
|
291
ResMed
RMD
$30.3B
| $289K | 0.15% |
+1,198
| New | +$306K |
|
292
Ferguson
FERG
$45B
| $289K | 0.15% |
1,296
+390
| +43% | +$93.2K |
|
293
TTM Technologies
TTMI
$11.3B
| $288K | 0.15% |
4,179
-49
| -1% | -$3.2K |
|
294
PBF Energy
PBF
$7.22B
| $288K | 0.15% |
10,616
-6,347
| -37% | -$203K |
|
295
America Movil
AMX
$77.2B
| $287K | 0.15% |
+13,869
| New | +$305K |
|
296
TriNet
TNET
$3.14B
| $286K | 0.15% |
+4,844
| New | +$288K |
|
|
NPKI
297
NPK International
NPKI
$1.09B
| $286K | 0.14% |
+23,980
| New | +$293K |
|
|
DAY
298
DELISTED
Dayforce
DAY
| $285K | 0.14% |
+4,126
| New | +$284K |
|
299
ITT
ITT
$17.8B
| $285K | 0.14% |
+1,644
| New | +$295K |
|
300
Hayward Holdings
HAYW
$3.28B
| $285K | 0.14% |
+18,458
| New | +$292K |
|
Similar funds
BS
RG
MP
CCM
DFA
CCP
FRT
VH
PharVision Advisers's Q4 2025 Portfolio in Review
As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.
- PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
- PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
- PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
- PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
- PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
- PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
- PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.
Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.